アポトーシスアッセイの世界市場予測(~2023年)

【英語タイトル】Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) - Global Forecast to 2023

MarketsandMarketsが出版した調査資料(BT-6742)・商品コード:BT-6742
・発行会社(調査会社):MarketsandMarkets
・発行日:2018年11月14日
・ページ数:207
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
アポトーシスアッセイの世界市場は、2018年の推定36億米ドルから2023年には59億米ドルに達し、10.5%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、慢性疾患および感染症の発生率および罹患率の増加、がん研究への資金提供の増加、細胞ベースの研究の増加、およびアポトーシス調節剤の開発が考えれられます。一方で、研究開発に必要な投資が多額にのぼることにより、市場の成長が抑制される可能性があります。当調査レポートでは、アポトーシスアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品(カスパーゼ、アネキシンV、DNA断片化、ミトコンドリアアッセイ)分析、検出技術(フローサイトメトリー、蛍光顕微鏡)分析、用途(幹細胞、創薬・開発、臨床研究)分析、アポトーシスアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

“The global apoptosis assays market is projected to grow at a CAGR of 10.5%”The apoptosis assays market is expected to reach USD 5.9 billion by 2023 from an estimated USD 3.6 billion in 2018, at a CAGR of 10.5%. The rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs are the key drivers for market growth. However, high investments required for research and development is expected to restrain the growth of this market to a certain extent during the forecast period.

“The flow cytometry segment to witness the highest growth during the forecast period”
On the basis of detection technology, the apoptosis assays market is segmented into flow cytometry, cell imaging & microscopy, spectrophotometry, and other detection technologies. The cell imaging & microscopy segment is expected to register the highest CAGR during the forecast period. The increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research is the major factor driving the growth of this market segment.

“The stem cell research applications segment is expected to grow at the highest CAGR during the forecast period”
On the basis of application, the apoptosis assays market is segmented into drug discovery & development, basic research, stem cell research, and clinical & diagnostic application. The stem cell research applications segment is expected to witness the highest CAGR owing to the increasing number of stem cell research activities and rising investments in stem cell research. Also government initiatives are expected to increase the number of cell-based research activities, which in turn will support the growth of the stem cell application segment.

“APAC is projected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global apoptosis assays market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries. Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region. With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R&D locations by manufacturers.

The breakdown of primary participants was as mentioned below:
• By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation: C-level–35%, Director Level–25%, and Others–40%
• By Region: North America–45%, Europe–20%, Asia Pacific–30%, and RoW–5%

The prominent players in the global apoptosis assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Becton, Dickinson and Company (US), GE Healthcare (US), Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US).

Research Coverage:
The report analyzes the various apoptosis products and their adoption pattern. It aims at estimating the market size and future growth potential of the global apoptosis assays market for different segments such as products, detection technology, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global apoptosis assays market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global apoptosis assays market
• Market Development: Comprehensive information on the lucrative emerging regions by product, detection technology, application, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global apoptosis assays market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global apoptosis assays market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
2.1.1 SECONDARY DATA 23
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 26
2.1.2.2 Break down of primary sources 27
2.2 MARKET SIZE ESTIMATION 27
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 MARKET SHARE ESTIMATION 30
2.5 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 35
4.1 APOPTOSIS ASSAYS MARKET OVERVIEW 35
4.2 APOPTOSIS ASSAYS MARKET: GEOGRAPHIC OVERVIEW (2017) 36
4.3 REGIONAL MIX: APOPTOSIS ASSAYS MARKET (2018–2023) 37
4.4 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY END USER & COUNTRY (2017) 38
4.5 APOPTOSIS ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Rising incidence and prevalence of chronic and infectious diseases 41
5.2.1.2 Growing funding for cancer research 42
5.2.1.3 Growing cell-based research 42
5.2.1.4 Development of apoptosis-modulating drugs 43
5.2.2 RESTRAINTS 44
5.2.2.1 High investments required for research and development 44
5.2.3 OPPORTUNITIES 44
5.2.3.1 Emerging markets 44
6 INDUSTRY INSIGHTS 46
6.1 INTRODUCTION 46
6.2 INDUSTRY TRENDS 46
6.2.1 INCREASING ADOPTION OF APOPTOSIS-TARGETING THERAPY IN CANCER TREATMENT 46
6.2.2 TECHNOLOGICAL ADVANCEMENTS 47
6.2.2.1 Label-free detection and imaging of apoptosis 47
6.2.2.2 Microfluidic devices for the analysis of apoptosis 47
6.3 UNMET NEED 48
6.3.1 UNAVAILABILITY OF 3D APOPTOSIS ASSAYS 48
7 APOPTOSIS ASSAYS MARKET, BY PRODUCT 49
7.1 INTRODUCTION 50
7.1.1 ASSAY KITS 51
7.1.1.1 Caspase assays 53
7.1.1.1.1 Caspase assays to dominate the assay kits market during the forecast period 53
7.1.1.2 Annexin V and cell permeability assays 54
7.1.1.2.1 Annexin V & cell permeability assays are among the most commonly used apoptosis assays due to their ability to bind to phosphatidylserine 54
7.1.1.3 DNA fragmentation assays 56
7.1.1.3.1 Ability to detect nuclear changes to drive the demand for DNA fragmentation assay kits 56
7.1.1.4 Mitochondrial assays 58
7.1.1.4.1 Merck, Thermo Fisher, Bio-Rad, and BD are among the key players in the mitochondrial assays segment 58
7.1.2 REAGENTS 59
7.1.3 INSTRUMENTS 60
7.1.4 MICROPLATES 61
8 APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY 63
8.1 INTRODUCTION 64
8.1.1 FLOW CYTOMETRY 65
8.1.1.1 Flow cytometry is the most popular apoptosis detection technology owing to its ability to provide quantitative multi-parametric analysis 65
8.1.2 CELL IMAGING AND MICROSCOPY 66
8.1.2.1 Ability to monitor cell physiology and examine complex cellular processes to drive the demand for cell imaging and microscopy technologies 66
8.1.3 SPECTROPHOTOMETRY 68
8.1.3.1 Lower instrument cost as compared to flow cytometers drives greater adoption of spectrophotometers in academic settings 68
8.1.4 OTHER DETECTION TECHNOLOGIES 69
9 APOPTOSIS ASSAYS MARKET, BY APPLICATION 70
9.1 INTRODUCTION 71
9.2 DRUG DISCOVERY AND DEVELOPMENT 72
9.2.1 DRUG DISCOVERY AND DEVELOPMENT FORMS THE LARGEST APPLICATION MARKET FOR APOPTOSIS ASSAYS 72
9.3 CLINICAL AND DIAGNOSTIC APPLICATIONS 73
9.3.1 RISING PREVALENCE OF CANCER, BLOOD-RELATED DISORDERS, & INFECTIOUS DISEASES DRIVING THE DEMAND FOR APOPTOSIS ASSAYS FOR CLINICAL & DIAGNOSTICS APPLICATIONS 73
9.4 BASIC RESEARCH 74
9.4.1 GROWING RESEARCH FUNDING FOR ACADEMIC INSTITUTIONS LIKELY TO SUPPORT THE DEMAND FOR APOPTOSIS ASSAYS IN BASIC RESEARCH 74
9.5 STEM CELL RESEARCH 76
9.5.1 RAPIDLY GROWING INTEREST IN REGENERATIVE THERAPIES DRIVING THE DEMAND FOR APOPTOSIS ASSAYS IN STEM CELL RESEARCH 76
10 APOPTOSIS ASSAYS MARKET, BY END USER 78
10.1 INTRODUCTION 79
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 80
10.2.1 RISING R&D ACTIVITIES & INTEREST TOWARDS DEVELOPMENT OF APOPTOSIS TARGETED THERAPIES LIKELY TO DRIVE THE MARKET GROWTH AMONG PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 80
10.3 HOSPITAL & DIAGNOSTIC LABORATORIES 82
10.3.1 INCREASING NUMBER OF HOSPITALS & HIGH PREVALENCE OF CHRONIC DISEASES TO DRIVE THE MARKET GROWTH AMONG HOSPITAL & DIAGNOSTIC LABORATORIES 82
10.4 ACADEMIC & RESEARCH INSTITUTES 83
10.4.1 GROWING DRUG DISCOVERY RESEARCH IN ACADEMIC INSTITUTIONS TO PROPEL THE DEMAND FOR APOPTOSIS ASSAYS 83
11 APOPTOSIS ASSAYS MARKET, BY REGION 85
11.1 INTRODUCTION 86
11.2 NORTH AMERICA 89
11.2.1 US 94
11.2.1.1 Increasing demand for early and effective disease diagnosis and treatment to drive the growth of the apoptosis assays market in the US 94
11.2.2 CANADA 96
11.2.2.1 Number of government initiatives to support life sciences research to drive the apoptosis assays market in Canada 96

11.3 EUROPE 100
11.3.1 GERMANY 103
11.3.1.1 Well-established R&D infrastructure & large number of academic research institutes account for large share of Germany in European apoptosis assays market 103
11.3.2 FRANCE 106
11.3.2.1 Support from government and private investors for promoting research in cell therapy to drive the growth of the apoptosis assays market in France 106
11.3.3 UK 109
11.3.3.1 Growing prevalence of cancer and neurological disorders & increasing R&D investments to drive the demand for apoptosis assays in the UK 109
11.3.4 ITALY 112
11.3.4.1 Increasing prevalence of target diseases driving the demand for apoptosis assays in Italy 112
11.3.5 SPAIN 115
11.3.5.1 Increasing private and public funding for cell-based research to drive the growth of the apoptosis assays market in Spain 115
11.3.6 REST OF EUROPE 118
11.4 ASIA PACIFIC 121
11.4.1 JAPAN 126
11.4.1.1 High prevalence of cancer and expansion of cancer research to drive the growth of the apoptosis assays market in Japan 126
11.4.2 CHINA 129
11.4.2.1 Increasing prevalence of chronic diseases and expanding biopharmaceutical research propelling the growth of the apoptosis assays market in China 129
11.4.3 INDIA 132
11.4.3.1 Geographic expansion of pharmaceutical companies and increasing cell-based research expected to drive the demand for apoptosis assays in India 132
11.4.4 REST OF ASIA PACIFIC 135
11.5 LATIN AMERICA 138
11.5.1 INCREASING FUNDING FOR LIFE SCIENCES RESEARCH TO DRIVE THE DEMAND FOR APOPTOSIS ASSAYS IN LATIN AMERICA 138
11.6 MIDDLE EAST & AFRICA 141
11.6.1 INCREASING NUMBER OF PARTNERSHIPS IN THE RESEARCH SECTOR DRIVING THE MARKET GROWTH IN THE MIDDLE EAST & AFRICA 141

12 COMPETITIVE LANDSCAPE 144
12.1 OVERVIEW 144
12.2 MARKET SHARE ANALYSIS 146
12.2.1 MARKET SHARE ANALYSIS: APOPTOSIS ASSAY KITS MARKET 146
12.3 COMPETITIVE SITUATION AND TRENDS 147
12.3.1 PRODUCT LAUNCHES 147
12.3.2 EXPANSIONS 148
12.3.3 ACQUISITIONS 149
12.3.4 OTHER STRATEGIES 149
13 COMPANY PROFILES 150
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 MERCK KGAA 150
13.2 THERMO FISHER SCIENTIFIC INC. 155
13.3 BECTON, DICKINSON AND COMPANY 161
13.4 BIO-RAD LABORATORIES 165
13.5 PROMEGA CORPORATION 168
13.6 ABCAM PLC 170
13.7 BIO-TECHNE CORPORATION 173
13.8 SARTORIUS AG 177
13.9 BIOTIUM 179
13.10 CREATIVE BIOARRAY (A PART OF CREATIVE DYNAMICS INC.) 181
13.11 GENO TECHNOLOGY, INC. 182
13.12 GENECOPOEIA, INC. 183
13.13 DANAHER CORPORATION 184
13.14 GE HEALTHCARE 188
13.15 BIOTEK INSTRUMENTS 191
13.16 PERKINELMER 194

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX 197
14.1 INSIGHTS OF INDUSTRY EXPERTS 197
14.2 DISCUSSION GUIDE 198
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 202
14.4 AVAILABLE CUSTOMIZATIONS 204
14.5 RELATED REPORTS 205
14.6 AUTHOR DETAILS 206

LIST OF TABLES

TABLE 1 APOPTOSIS ASSAYS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS,
AND OPPORTUNITIES 40
TABLE 2 GLOBAL CANCER INCIDENCE 41
TABLE 3 APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 50
TABLE 4 APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 51
TABLE 5 APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 52
TABLE 6 APOPTOSIS ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 52
TABLE 7 LIST OF SOME OF THE CASPASE ASSAY KITS OFFERED BY PROMINENT PLAYERS 53
TABLE 8 CASPASE ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 54
TABLE 9 LIST OF SOME OF THE ANNEXIN ASSAY KITS OFFERED BY PROMINENT PLAYERS 55
TABLE 10 ANNEXIN V AND CELL PERMEABILITY ASSAY KITS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 56
TABLE 11 LIST OF SOME OF THE DNA FRAGMENTATION ASSAY KITS OFFERED
BY PROMINENT PLAYERS 57
TABLE 12 DNA FRAGMENTATION ASSAY KITS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 57
TABLE 13 LIST OF SOME OF THE MITOCHONDRIAL ASSAY KITS OFFERED
BY PROMINENT PLAYERS 58
TABLE 14 MITOCHONDRIAL ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 59
TABLE 15 APOPTOSIS REAGENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 60
TABLE 16 APOPTOSIS INSTRUMENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 17 APOPTOSIS MICROPLATES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 62
TABLE 18 APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 65
TABLE 19 FLOW CYTOMETRY MARKET FOR APOPTOSIS DETECTION,
BY COUNTRY, 2016–2023 (USD MILLION) 66
TABLE 20 CELL IMAGING AND MICROSCOPY MARKET FOR APOPTOSIS DETECTION,
BY COUNTRY, 2016–2023 (USD MILLION) 67
TABLE 21 SPECTROPHOTOMETRY MARKET FOR APOPTOSIS DETECTION,
BY COUNTRY, 2016–2023 (USD MILLION) 68
TABLE 22 OTHER DETECTION TECHNOLOGIES MARKET FOR APOPTOSIS DETECTION,
BY COUNTRY, 2016–2023 (USD MILLION) 69
TABLE 23 APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 71
TABLE 24 APOPTOSIS ASSAYS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT,
BY COUNTRY, 2016–2023 (USD MILLION) 72
TABLE 25 APOPTOSIS ASSAYS MARKET FOR CLINICAL AND DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 74
TABLE 26 APOPTOSIS ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY,
2016–2023 (USD MILLION) 75
TABLE 27 APOPTOSIS ASSAYS MARKET FOR STEM CELL RESEARCH, BY COUNTRY,
2016–2023 (USD MILLION) 77
TABLE 28 APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 79
TABLE 29 APOPTOSIS ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 81
TABLE 30 APOPTOSIS ASSAYS MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2016–2023 (USD MILLION) 82
TABLE 31 APOPTOSIS ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2016–2023 (USD MILLION) 84
TABLE 32 APOPTOSIS ASSAYS MARKET, BY REGION, 2016–2023 (USD MILLION) 87
TABLE 33 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 91
TABLE 34 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 91
TABLE 35 NORTH AMERICA: APOPTOSIS ASSAY KITS MARKET, BY TYPE,
2016–2023 (USD MILLION) 92
TABLE 36 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION) 92
TABLE 37 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 93
TABLE 38 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 93
TABLE 39 US: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 94
TABLE 40 US: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 95
TABLE 41 US: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 95
TABLE 42 US: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 96
TABLE 43 US: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 96
TABLE 44 CANADA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 97
TABLE 45 CANADA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 98
TABLE 46 CANADA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 98
TABLE 47 CANADA: APOPTOSIS ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 99
TABLE 48 CANADA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 99
TABLE 49 EUROPE: APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 100
TABLE 50 EUROPE: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 101
TABLE 51 EUROPE: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 101
TABLE 52 EUROPE: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 102
TABLE 53 EUROPE: APOPTOSIS ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 102
TABLE 54 EUROPE: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 103
TABLE 55 GERMANY: APOPTOSIS ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 104
TABLE 56 GERMANY: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 104
TABLE 57 GERMANY: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 105
TABLE 58 GERMANY: APOPTOSIS ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 105
TABLE 59 GERMANY: APOPTOSIS ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 106
TABLE 60 FRANCE: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 107
TABLE 61 FRANCE: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 107
TABLE 62 FRANCE: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 108
TABLE 63 FRANCE: APOPTOSIS ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 108
TABLE 64 FRANCE: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 109
TABLE 65 UK: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 110
TABLE 66 UK: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 110
TABLE 67 UK: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 111
TABLE 68 UK: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 111
TABLE 69 UK: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 112
TABLE 70 ITALY: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 113
TABLE 71 ITALY: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 113
TABLE 72 ITALY: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 114
TABLE 73 ITALY: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 114
TABLE 74 ITALY: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 115
TABLE 75 SPAIN: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 116
TABLE 76 SPAIN: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 116
TABLE 77 SPAIN: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 117
TABLE 78 SPAIN: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 117
TABLE 79 SPAIN: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 118
TABLE 80 ROE: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 118
TABLE 81 ROE: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 119
TABLE 82 ROE: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 119
TABLE 83 ROE: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 120
TABLE 84 ROE: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 120
TABLE 85 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 123
TABLE 86 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 123
TABLE 87 ASIA PACIFIC: APOPTOSIS ASSAY KITS MARKET, BY TYPE,
2016–2023 (USD MILLION) 124
TABLE 88 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 124
TABLE 89 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 125
TABLE 90 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 125
TABLE 91 JAPAN: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 126
TABLE 92 JAPAN: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 127
TABLE 93 JAPAN: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 127
TABLE 94 JAPAN: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 128
TABLE 95 JAPAN: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 128
TABLE 96 CHINA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 129
TABLE 97 CHINA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 130
TABLE 98 CHINA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 130
TABLE 99 CHINA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 131
TABLE 100 CHINA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 131
TABLE 101 INDIA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 132
TABLE 102 INDIA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 133
TABLE 103 INDIA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 133
TABLE 104 INDIA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 134
TABLE 105 INDIA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 134
TABLE 106 ROAPAC: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 135
TABLE 107 ROAPAC: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION) 136
TABLE 108 ROAPAC: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY,
2016–2023 (USD MILLION) 136
TABLE 109 ROAPAC: APOPTOSIS ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 137
TABLE 110 ROAPAC: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 137
TABLE 111 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 138
TABLE 112 LATIN AMERICA: APOPTOSIS ASSAY KITS MARKET, BY TYPE,
2016–2023 (USD MILLION) 139
TABLE 113 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION) 139
TABLE 114 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 140
TABLE 115 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 140
TABLE 116 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 141
TABLE 117 MIDDLE EAST & AFRICA: APOPTOSIS ASSAY KITS MARKET, BY TYPE,
2016–2023 (USD MILLION) 142
TABLE 118 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION) 142
TABLE 119 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 143
TABLE 120 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 143
TABLE 121 GROWTH STRATEGY MATRIX (2015–2018) 145
TABLE 122 PRODUCT LAUNCHES, 2015–2018 148
TABLE 123 EXPANSIONS, 2015–2018 148
TABLE 124 ACQUISITIONS, 2015–2018 149
TABLE 125 OTHER STRATEGIES, 2015–2018 149


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 23
FIGURE 2 PRIMARY SOURCES 25
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 27
FIGURE 4 BOTTOM-UP APPROACH 28
FIGURE 5 TOP-DOWN APPROACH 28
FIGURE 6 DATA TRIANGULATION METHODOLOGY 29
FIGURE 7 APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION) 31
FIGURE 8 APOPTOSIS DETECTION TECHNOLOGY MARKET, BY TYPE,
2018 VS. 2023 (USD MILLION) 32
FIGURE 9 APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 32
FIGURE 10 APOPTOSIS ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 33
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE APOPTOSIS ASSAYS MARKET 34
FIGURE 12 RISING INCIDENCE AND PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
IS EXPECTED TO DRIVE MARKET GROWTH 35
FIGURE 13 THE US DOMINATED THE APOPTOSIS ASSAYS MARKET IN 2017 36
FIGURE 14 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018–2023) 37
FIGURE 15 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE APAC APOPTOSIS ASSAYS MARKET IN 2017 38
FIGURE 16 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 39
FIGURE 17 DRIVERS, RESTRAINTS, AND OPPORTUNITIES: APOPTOSIS ASSAYS MARKET 40
FIGURE 18 ASSAY KITS SEGMENT TO DOMINATE THE APOPTOSIS ASSAYS MARKET,
BY PRODUCT, DURING THE FORECAST PERIOD 50
FIGURE 19 FLOW CYTOMETRY TO DOMINATE THE APOPTOSIS ASSAYS MARKET DURING
THE FORECAST PERIOD 64
FIGURE 20 DRUG DISCOVERY AND DEVELOPMENT ESTIMATED TO BE THE LARGEST APPLICATION SEGMENT IN THE APOPTOSIS ASSAYS MARKET IN 2018 71
FIGURE 21 APOPTOSIS ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 79
FIGURE 22 APOPTOSIS ASSAYS MARKET: GEOGRAPHICAL SNAPSHOT (2017) 86
FIGURE 23 NORTH AMERICA TO DOMINATE THE APOPTOSIS ASSAYS MARKET DURING THE FORECAST PERIOD 88
FIGURE 24 NORTH AMERICA: APOPTOSIS ASSAYS MARKET SNAPSHOT 90
FIGURE 25 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET SNAPSHOT 122
FIGURE 26 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2015 TO MAY 2018 144
FIGURE 27 APOPTOSIS ASSAYS KITS MARKET, BY KEY PLAYER, 2017 146
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2017) 151
FIGURE 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 155
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017) 161
FIGURE 31 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017) 165
FIGURE 32 ABCAM PLC: COMPANY SNAPSHOT (2017) 170

FIGURE 33 BIO-TECHNE: COMPANY SNAPSHOT (2018) 173
FIGURE 34 SARTORIUS AG: COMPANY SNAPSHOT (2017) 177
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2017) 184
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT (2017) 188
FIGURE 37 PERKINELMER: COMPANY SNAPSHOT (2017) 194


★調査レポート[アポトーシスアッセイの世界市場予測(~2023年)] (コード:BT-6742)販売に関する免責事項を必ずご確認ください。
★調査レポート[アポトーシスアッセイの世界市場予測(~2023年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆